DOSIMETRY OF VERY SMALL PHOTON FIELDS by Kamen A. Paskalev Dep artment ofMedical Physics McGill University, Montreal May 2002 A thesis su bmitted to the Faculty of Graduate…

DRUG ACTION: PHARMACEUTIC, PHARMACOKINETIC, AND PHARMACODYNAMIC PHASES  Differentiate the 3 phases of drug action  Identify the 2 processes that occur before tablets…

MICROREVIEW DOI: 10.1002/ejoc.201100407 The Bacterial Lectin FimH, a Target for Drug Discovery – Carbohydrate Inhibitors of Type 1 Fimbriae-Mediated Bacterial Adhesion…

1. Adelaide Health Technology Assessment (AHTA)Monday, June 25, 2012HOW TO ASSESS PERSONALISED MEDICINESFOR REIMBURSEMENT DECISIONS?Developing a framework for AustraliaTracy…

1. “Big Data” in Cancer Control & Prevention Bradford W. Hesse, PhD Chief, Health Communication & Informatics Research Thursday, February 9, 2012 2. Thursday,…

1. Adaptive Design Ana Ruiz Paul Bycott 2. Definition Clinical study design that uses accumulating data to decide on how to modify aspects of the study as it continues, without…

Slide 1{ Dose Response to Vitamin D Supplementation in Postmenopausal Women Annals of Internal Med. 2012; 156:425-437 Jayme Bristow Slide 2 To determine the effect of increasing…

Slide 1The Health Services Researcher of 2020: A Summit on the Future of HSR Data and Methods Learning 2.0: Robust, Rigorous, Relevant, and Rapid Paul Wallace MD Permanente…

Slide 1Issues on Recent Drug Development in Japan Masahiro Takeuchi Hajime Uno Fumiaki Takahashi Slide 2 Outline Introduction Clinical Trial Environment Recent R&D Trend…

Slide 11 Multiplicity Adjustment For Clinical Trials with Two Doses of an Active Treatment and Multiple Primary and Secondary Endpoints Hui Quan 1, Tom Capizzi 1, Ji Zhang…